clinical trials/ BE studies for locally acting drugs [Regulatives / Guidelines]

posted by jagankm  – 2012-02-06 13:00 (5251 d 17:41 ago) – Posting: # 8056
Views: 6,276

thank you for your response.

as per US FDA guidlines we have to conduct two BE studies both in fasting and fed conditions for sulfasalazine.
but we are in ambiguity to show BE for this molecule.

for docusate sodium, it is a solution in soft gelatin capsuls, as per the EMEA guidlines on locally acting liquids we may go for biowaivers.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
131 visitors (0 registered, 131 guests [including 13 identified bots]).
Forum time: 07:42 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5